Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3773109014 | Product containing only carmustine in prolonged-release intralesional implant (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3773110016 | Carmustine only product in prolonged-release intralesional implant | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only carmustine in prolonged-release intralesional implant (medicinal product form) | Is a | Product containing carmustine in prolonged-release intralesional implant (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only carmustine in prolonged-release intralesional implant (medicinal product form) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing only carmustine in prolonged-release intralesional implant (medicinal product form) | Is a | Carmustine | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only carmustine in prolonged-release intralesional implant (medicinal product form) | Has manufactured dose form | Prolonged-release intralesional implant | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only carmustine in prolonged-release intralesional implant (medicinal product form) | Has active ingredient | Carmustine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing only carmustine in prolonged-release intralesional implant (medicinal product form) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) | Is a | True | Product containing only carmustine in prolonged-release intralesional implant (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR